Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cefepime-metroNIDAZOLE

cefepime-metroNIDAZOLE
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Maximet SOLUTION, INTRAVENOUS 1 g-500 mg, 1 g- 750 mg, 1 g-1,500 mg      
Comments:

Common "Maximet" regimens include:

  • Cefepime 1 g-metroNIDAZOLE 500 mg q8h
  • Cefepime 1 g-metroNIDAZOLE 750 mg q12h
  • Cefepime 1 g-metroNIDAZOLE 1,500 mg q24h

Cefepime doses of up to 2 grams q8hrs can be used for serious infections.

 

Approved by Antibiotic Sub-committee

Reviewed: 25 Sept 2003

Last updated: May. 20, 2016






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved